Home › Esophageal Squamous Cell Carcinoma › Oregon › Portland
Esophageal Squamous Cell Carcinoma clinical trials in Portland, OR
4 studies for Esophageal Squamous Cell Carcinoma are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RecruitingPhase 1
- ALX Center 6, Portland
A Study of MGC026 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Providence Cancer Institute, Portland
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RecruitingPhase 1
- Providence Cancer Institute Franz Clinic, Portland
- Providence Oncology and Hematology Care Clinic - Westside, Portland
- Providence St. Vincent Medical Center- Investigational Drug Services, Portland
- and 1 more
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
RecruitingPhase 2
- VA Portland Health Care System, Portland, OR, Portland
Esophageal Squamous Cell Carcinoma trials in other cities
- Arlington, VA14 studies
- Nashville, TN12 studies
- Houston, TX12 studies
- Los Angeles, CA11 studies
- Baldwin Park, CA8 studies
- West Valley City, UT7 studies
- San Antonio, TX7 studies
- New York City, NY7 studies
- Santa Monica, CA6 studies
- Queens, NY6 studies
- Dallas, TX5 studies
- Boston, MA5 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Breast Cancer33 studies
- Prostate Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.